NORAM LITHIUM CORP (NRM.CA) Fundamental Analysis & Valuation

TSX-V:NRM • CA65542K1030

Current stock price

0.15 CAD
-0.01 (-6.25%)
Last:

This NRM.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. NRM.CA Profitability Analysis

1.1 Basic Checks

  • In the past year NRM has reported negative net income.
  • In the past year NRM has reported a negative cash flow from operations.
  • In the past 5 years NRM always reported negative net income.
  • NRM had a negative operating cash flow in each of the past 5 years.
NRM.CA Yearly Net Income VS EBIT VS OCF VS FCFNRM.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M

1.2 Ratios

  • NRM has a Return On Assets (-40.03%) which is comparable to the rest of the industry.
  • NRM has a Return On Equity (-50.46%) which is in line with its industry peers.
Industry RankSector Rank
ROA -40.03%
ROE -50.46%
ROIC N/A
ROA(3y)-50.07%
ROA(5y)-67.78%
ROE(3y)-53.46%
ROE(5y)-73.08%
ROIC(3y)N/A
ROIC(5y)N/A
NRM.CA Yearly ROA, ROE, ROICNRM.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -100 -200 -300

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for NRM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NRM.CA Yearly Profit, Operating, Gross MarginsNRM.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

1

2. NRM.CA Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for NRM has been increased compared to 1 year ago.
  • The number of shares outstanding for NRM has been increased compared to 5 years ago.
  • NRM has a worse debt/assets ratio than last year.
NRM.CA Yearly Shares OutstandingNRM.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
NRM.CA Yearly Total Debt VS Total AssetsNRM.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M

2.2 Solvency

  • Based on the Altman-Z score of 0.17, we must say that NRM is in the distress zone and has some risk of bankruptcy.
  • NRM has a Altman-Z score of 0.17. This is in the lower half of the industry: NRM underperforms 60.10% of its industry peers.
  • A Debt/Equity ratio of 0.01 indicates that NRM is not too dependend on debt financing.
  • The Debt to Equity ratio of NRM (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACCN/A
NRM.CA Yearly LT Debt VS Equity VS FCFNRM.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M

2.3 Liquidity

  • NRM has a Current Ratio of 0.15. This is a bad value and indicates that NRM is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Current ratio value of 0.15, NRM is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
  • A Quick Ratio of 0.15 indicates that NRM may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.15, NRM is doing worse than 78.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
NRM.CA Yearly Current Assets VS Current LiabilitesNRM.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M

0

3. NRM.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 29.23% over the past year.
EPS 1Y (TTM)29.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.95%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. NRM.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • NRM reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NRM.CA Price Earnings VS Forward Price EarningsNRM.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NRM.CA Per share dataNRM.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.02 -0.02 0.04

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. NRM.CA Dividend Analysis

5.1 Amount

  • No dividends for NRM!.
Industry RankSector Rank
Dividend Yield 0%

NRM.CA Fundamentals: All Metrics, Ratios and Statistics

NORAM LITHIUM CORP

TSX-V:NRM (3/13/2026, 7:00:00 PM)

0.15

-0.01 (-6.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)12-29
Earnings (Next)06-01
Inst Owners5.8%
Inst Owner ChangeN/A
Ins Owners9.11%
Ins Owner ChangeN/A
Market Cap15.02M
Revenue(TTM)N/A
Net Income(TTM)-2.31M
Analysts84.44
Price Target1.16 (673.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 3.28
P/tB 3.28
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.03%
ROE -50.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-50.07%
ROA(5y)-67.78%
ROE(3y)-53.46%
ROE(5y)-73.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.01%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z 0.17
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)3838.09%
Cap/Depr(5y)2641.43%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%16.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y31.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y90.76%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y87.6%
OCF growth 3YN/A
OCF growth 5YN/A

NORAM LITHIUM CORP / NRM.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for NORAM LITHIUM CORP?

ChartMill assigns a fundamental rating of 1 / 10 to NRM.CA.


Can you provide the valuation status for NORAM LITHIUM CORP?

ChartMill assigns a valuation rating of 0 / 10 to NORAM LITHIUM CORP (NRM.CA). This can be considered as Overvalued.


What is the profitability of NRM stock?

NORAM LITHIUM CORP (NRM.CA) has a profitability rating of 1 / 10.